Our ICT Winter issue is now live!☃️
https://t.co/JUVAjy8AGp
https://t.co/R4ZVz7CbZP
Check it out for features on Patient Recruitment, Oncological Research and Trials, and Rare Disease Trials. This issue also includes the second edition of Certara's Medical Writing Supplement!
🦸♀️The power of decentralised: rebalancing clinical trials through innovative technology to put patients first
✏️Steve Sanghera at Inventus Group
Read here: https://t.co/tfbAoAbyGr
🏎️The Force Behind the Speed: The Next Lap🏎️
Setting the pace: writing an effective Module 2.4 non-clinical overview
✏️Brenda Taylor and Kelly Smith at @Certara
Read here: https://t.co/S9O3TQL00W
🏎️The Force Behind the Speed: The Next Lap🏎️
From algorithms to accountability: the human core of AI-driven medical writing
✏️Reema SelvaRaju at @Certara
Read here: https://t.co/Bip6E8Id7v
🏎️The Force Behind the Speed: The Next Lap🏎️
Navigating regulatory submissions: how to avoid common mistakes
✏️Rachel Bombara at @Certara
Read here: https://t.co/oXyWliM3lp
🏎️The Force Behind the Speed: The Next Lap🏎️
Rolling NDA and BLA submissions: accelerate your review
✏️Janet Shoshitaishvili at @Certara
Read here: https://t.co/JeGzricSSr
🏎️The Force Behind the Speed: The Next Lap🏎️
Efficient personalisation: mastering style guides and lexicons for tailored submissions
✏️Sarah Steffin at @Certara
Read here: https://t.co/03NtcoBBSu
🏎️The Force Behind the Speed🏎️
Strategies and best practices for periodic aggregate safety report authoring
✏️Nicholas Churton, Mary Pilkington and Sarah Threlfell at @Certara
Read here: https://t.co/Kv1TDOtBhZ
🏎️The Force Behind the Speed: The Next Lap🏎️
Web of evidence: document dependencies
✏️Kristen Brotzman, Brenda Taylor and Steve Sibley at @Certara
Read here: https://t.co/o7XX6AfvYH
🏎️The Force Behind the Speed: The Next Lap🏎️
A cross-functional collaborative approach to authoring disclosure-ready submission documents
✏️Anaya Rehman, Honz Slipka, Gunia Kaur and Michael Pattison at @Certara
Read here: https://t.co/EJy9YvLApl
👩🏫Neuroscience biomarkers: lessons for navigating the new frontier
✏️Richard Bennett and Peter Böhm at Worldwide Clinical Trials
Read here: https://t.co/6reFygjLRm
🧬AAV production for rare disease therapies: from challenge to solution
✏️James Cody at Charles River Laboratories and Gai Ayalon at @Foxg1Research
Read here: https://t.co/mXFhwhkHIm
💪Advancing hope: the evolving clinical trials landscape in neuromuscular diseases
✏️Brian Lin at the Muscular Dystrophy Association
Read here: https://t.co/I77x046WGB
☢️How to overcome operational challenges of radiotherapeutic clinical trials to advance oncology treatment
✏️Gabriela Rosu at @VeristatCRO
Read here: https://t.co/UknAsrNxqQ